Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · IEX Real-Time Price · USD
-1.060 (-26.30%)
At close: Jun 18, 2024, 4:00 PM
-0.110 (-3.70%)
After-hours: Jun 18, 2024, 6:15 PM EDT

Taysha Gene Therapies Market Cap

Taysha Gene Therapies has a market cap or net worth of $555.44 million as of June 18, 2024. Its market cap has increased by 906.24% in one year.

Market Cap
Enterprise Value
1-Year Change
Stock Price

Market Cap Chart

Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has decreased from $690.43M to $555.44M, a decrease of -19.55%. That is a compound annual growth rate of -5.66%.


DateMarket Cap% Change
Jun 17, 2024753.70M1.51%
Jun 14, 2024742.50M-4.80%
Jun 13, 2024779.90M6.66%
Jun 12, 2024731.20M4.26%
Jun 11, 2024701.30M-4.34%
Jun 10, 2024733.10M-0.76%
Jun 7, 2024738.70M2.33%
Jun 6, 2024721.90M-3.26%
Jun 5, 2024746.20M8.43%
Jun 4, 2024688.20M1.65%
Jun 3, 2024677.00M5.53%
May 31, 2024641.50M9.58%
May 30, 2024585.40M-1.25%
May 29, 2024592.80M-2.47%
May 28, 2024607.80M0.31%
May 24, 2024605.90M9.45%
May 23, 2024553.60M-0.32%
May 22, 2024555.40M2.76%
May 21, 2024540.50M-6.47%
May 20, 2024577.90M-
May 17, 2024577.90M-1.58%
May 16, 2024587.20M0.96%
May 15, 2024581.60M21.02%
May 14, 2024480.60M7.09%
May 13, 2024448.80M2.56%
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
PureTech Health 778.52M
Prime Medicine 762.20M
Healthcare Services Group 761.50M
HilleVax 760.23M
Arcturus Therapeutics Holdings 757.59M
Cytek Biosciences 745.63M
Dianthus Therapeutics 741.37M
Humacyte 737.13M
Market Cap Rankings